Ladina DiRago
Walter and Eliza Hall Institute of Medical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ladina DiRago.
Immunity | 2004
Ben A. Croker; Donald Metcalf; Lorraine Robb; Wei Wei; Sandra Mifsud; Ladina DiRago; Leonie A. Cluse; Kate D. Sutherland; Lynne Hartley; Emily Williams; Jian-Guo Zhang; Douglas J. Hilton; Nicos A. Nicola; Warren S. Alexander; Andrew W. Roberts
To determine the importance of suppressor of cytokine signaling-3 (SOCS3) in the regulation of hematopoietic growth factor signaling generally, and of G-CSF-induced cellular responses specifically, we created mice in which the Socs3 gene was deleted in all hematopoietic cells. Although normal until young adulthood, these mice then developed neutrophilia and a spectrum of inflammatory pathologies. When stimulated with G-CSF in vitro, SOCS3-deficient cells of the neutrophilic granulocyte lineage exhibited prolonged STAT3 activation and enhanced cellular responses to G-CSF, including an increase in cloning frequency, survival, and proliferative capacity. Consistent with the in vitro findings, mutant mice injected with G-CSF displayed enhanced neutrophilia, progenitor cell mobilization, and splenomegaly, but unexpectedly also developed inflammatory neutrophil infiltration into multiple tissues and consequent hind-leg paresis. We conclude that SOCS3 is a key negative regulator of G-CSF signaling in myeloid cells and that this is of particular significance during G-CSF-driven emergency granulopoiesis.
Journal of Leukocyte Biology | 1999
Warren S. Alexander; Robyn Starr; Donald Metcalf; Sandra E. Nicholson; Alison Farley; Andrew G. Elefanty; Marta Brysha; Benjamin T. Kile; Rachel Richardson; Manuel Baca; Jian-Guo Zhang; Tracy A. Willson; Elizabeth M. Viney; Naomi S. Sprigg; Steven Rakar; Jason Corbin; Sandra Mifsud; Ladina DiRago; Dale Cary; Nicos A. Nicola; Douglas J. Hilton
SOCS‐1 was originally identified as an inhibitor of interleukin‐6 signal transduction and is a member of a family of proteins (SOCS‐1 to SOCS‐7 and CIS) that contain an SH2 domain and a conserved carboxyl‐terminal SOCS box motif. Mutation studies have established that critical contributions from both the amino‐terminal and SH2 domains are essential for SOCS‐1 and SOCS‐3 to inhibit cytokine signaling. Inhibition of cytokine‐dependent activation of STAT3 occurred in cells expressing either SOCS‐1 or SOCS‐3, but unlike SOCS‐1, SOCS‐3 did not directly interact with or inhibit the activity of JAK kinases. Although the conserved SOCS box motif appeared to be dispensable for SOCS‐1 and SOCS‐3 action when over‐expressed, this domain interacts with elongin proteins and may be important in regulating protein turnover. In gene knockout studies, SOCS‐1−/− mice were born but failed to thrive and died within 3 weeks of age with fatty degeneration of the liver and hemopoietic infiltration of several organs. The thymus in SOCS‐1−/− mice was small, the animals were lymphopenic, and deficiencies in B lymphocytes were evident within hemopoietic organs. We propose that the absence of SOCS‐1 in these mice prevents lymphocytes and liver cells from appropriately controlling signals from cytokines with cytotoxic side effects. J. Leukoc. Biol. 66: 588–592; 1999.
Molecular and Cellular Biology | 2001
Benjamin T. Kile; Donald Metcalf; Sandra Mifsud; Ladina DiRago; Nicos A. Nicola; Douglas J. Hilton; Warren S. Alexander
ABSTRACT The Asbs are a family of ankyrin repeat proteins that, along with four other protein families, contain a C-terminal SOCS box motif, which was first identified in the suppressor of cytokine signaling (SOCS) proteins. While it is clear that the SOCS proteins are involved in the negative regulation of cytokine signaling, the biological roles of the other SOCS box-containing families are unknown. We have investigated Asb-1 function by generating mice that lack this protein, as well as mice that overexpress full-length or truncated Asb-1 in a wide range of tissues. Although Asb-1 is expressed in multiple organs, including the hematopoietic compartment in wild-type mice, Asb-1−/−mice develop normally and exhibit no anomalies of mature blood cells or their progenitors. While most organs in these mice appear normal, the testes of Asb-1−/− mice display a diminution of spermatogenesis with less complete filling of seminiferous tubules. In contrast, the widespread overexpression of Asb-1 in the mouse has no apparent deleterious effects.
Cell Metabolism | 2016
Andrew J. Murphy; Michael J. Kraakman; Helene L. Kammoun; Dragana Dragoljevic; Man K.S. Lee; Kate E. Lawlor; John M. Wentworth; Ajithkumarx Vasanthakumar; Motti Gerlic; Lachlan Whitehead; Ladina DiRago; Louise H. Cengia; Rachael M. Lane; Donald Metcalf; James E. Vince; Leonard C. Harrison; Axel Kallies; Benjamin T. Kile; Ben A. Croker; Mark A. Febbraio; Seth L. Masters
Interleukin-18 (IL-18) is activated by Caspase-1 in inflammasome complexes and has anti-obesity effects; however, it is not known which inflammasome regulates this process. We found that mice lacking the NLRP1 inflammasome phenocopy mice lacking IL-18, with spontaneous obesity due to intrinsic lipid accumulation. This is exacerbated when the mice are fed a high-fat diet (HFD) or a high-protein diet, but not when mice are fed a HFD with low energy density (high fiber). Furthermore, mice with an activating mutation in NLRP1, and hence increased IL-18, have decreased adiposity and are resistant to diet-induced metabolic dysfunction. Feeding these mice a HFD further increased plasma IL-18 concentrations and strikingly resulted in loss of adipose tissue mass and fatal cachexia, which could be prevented by genetic deletion of IL-18. Thus, NLRP1 is an innate immune sensor that functions in the context of metabolic stress to produce IL-18, preventing obesity and metabolic syndrome.
Journal of Immunology | 2014
Hongsheng Wang; Ming Yan; Jiafang Sun; Shweta Jain; Ryusuke Yoshimi; Sanaz Momben Abolfath; Keiko Ozato; William G. Coleman; Ashley P. Ng; Donald Metcalf; Ladina DiRago; Stephen L. Nutt; Herbert C. Morse
The IFN regulatory factor family member 8 (IRF8) regulates differentiation of lymphoid and myeloid lineage cells by promoting or suppressing lineage-specific genes. How IRF8 promotes hematopoietic progenitors to commit to one lineage while preventing the development of alternative lineages is not known. In this study, we report an IRF8–EGFP fusion protein reporter mouse that revealed previously unrecognized patterns of IRF8 expression. Differentiation of hematopoietic stem cells into oligopotent progenitors is associated with progressive increases in IRF8-EGFP expression. However, significant induction of IRF8-EGFP is found in granulocyte–myeloid progenitors and the common lymphoid progenitors but not the megakaryocytic–erythroid progenitors. Surprisingly, IRF8-EGFP identifies three subsets of the seemingly homogeneous granulocyte–myeloid progenitors with an intermediate level of expression of EGFP defining bipotent progenitors that differentiation into either EGFPhi monocytic progenitors or EGFPlo granulocytic progenitors. Also surprisingly, IRF8-EGFP revealed a highly heterogeneous pre–pro-B population with a fluorescence intensity ranging from background to 4 orders above background. Interestingly, IRF8–EGFP readily distinguishes true B cell committed (EGFPint) from those that are noncommitted. Moreover, dendritic cell progenitors expressed extremely high levels of IRF8-EGFP. Taken together, the IRF8-EGFP reporter revealed previously unrecognized subsets with distinct developmental potentials in phenotypically well-defined oligopotent progenitors, providing new insights into the dynamic heterogeneity of developing hematopoietic progenitors.
Proceedings of the National Academy of Sciences of the United States of America | 2006
Stefan Glaser; Donald Metcalf; Li Wu; Adam H. Hart; Ladina DiRago; Sandra Mifsud; Angela D'Amico; Samantha Dagger; Chiara Campo; Angela C. Chan; David J. Izon; Lorraine Robb
Mixl1, the sole murine homologue of the Xenopus Mix/Bix family of homeobox transcription factors, is essential for the patterning of axial mesendodermal structures during early embryogenesis. Gene targeting and overexpression studies have implicated Mixl1 as a regulator of hematopoiesis arising in differentiating embryonic stem cells. To assess the role of Mixl1 in the regulation of adult hematopoiesis, we overexpressed Mixl1 in murine bone marrow using a retroviral transduction/transplantation model. Enforced expression of Mixl1 profoundly perturbed hematopoietic lineage commitment and differentiation, giving rise to abnormal myeloid progenitors and impairing erythroid and lymphoid differentiation. Moreover, all mice reconstituted with Mixl1-transduced bone marrow developed fatal, transplantable acute myeloid leukemia with a mean latency period of 200 days. These observations establish a link between enforced Mixl1 expression and leukemogenesis in the mouse.
Blood | 2005
Donald Metcalf; Marina R. Carpinelli; Craig D. Hyland; Sandra Mifsud; Ladina DiRago; Nicos A. Nicola; Douglas J. Hilton; Warren S. Alexander
Journal of Cell Biology | 2015
Man Lyang Kim; Jae Jin Chae; Yong Hwan Park; Dominic De Nardo; Roslynn A. Stirzaker; Hyun-Ja Ko; Hazel Tye; Louise H. Cengia; Ladina DiRago; Donald Metcalf; Andrew W. Roberts; Daniel L. Kastner; Andrew M. Lew; Dena Lyras; Benjamin T. Kile; Ben A. Croker; Seth L. Masters
Journal of Immunology | 2014
Hongsheng Wang; Ming Yan; Jiafang Sun; Shweta Jain; Ryusuke Yoshimi; Sanaz Momben Abolfath; Keiko Ozato; William G. Coleman; Ashley P. Ng; Donald Metcalf; Ladina DiRago; Stephen L. Nutt; Herbert C. Morse
Journal of Immunology | 2014
Hongsheng Wang; Ming Yan; Jiafang Sun; Shweta Jain; Ryusuke Yoshimi; Sanaz Momben Abolfath; Keiko Ozato; William G. Coleman; Ashley P. Ng; Donald Metcalf; Ladina DiRago; Stephen L. Nutt; Herbert C. Morse